Clinical Trial Update: Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC) [Phase 2]

View source ↗

Summary

Clinical Trial Update reporting a Phase II study of Hamsa-1 in metastatic castration-resistant prostate cancer, sponsored by Tiltan Pharma Ltd; the current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Hamsa-1

Snippet

Sponsor: Tiltan Pharma Ltd. | Conditions: Metastatic Castration Resistant Prostate Cancer (CRPC) | Phase 2 | Status: UNKNOWN